Demonstration of safety of probiotics - A review

International Journal of Food Microbiology

Volumn 44, Issue 1-2, 1998, Pages 93-106

  Salminen, Seppo ^a   Von Wright, Atte ^b   Morelli, Lorenzo ^c   Marteau, Philippe ^d   Brassart, Dominique ^e   De Vos, Willem M ^f   Fondén, Rangne ^g   Saxelin, Maija ^h   Collins, Kevin ⁱ   Mogensen, Gunnar ^j   Birkeland, Stein Erik ^k   Mattila Sandholm, Tiina ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^c UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

^d Hopital Laennec   (France)

^e NESTLÉ RESEARCH CENTER   (Switzerland)

^f WAGENINGEN UNIVERSITY   (Netherlands)

^g Arla Foods   (Denmark)

^h VALIO LTD   (Finland)

ⁱ UNIVERSITY COLLEGE CORK   (Ireland)

^j CHR HANSEN A S   (Denmark)

^k TINE SA   (Norway)

more..

Author keywords

Antibiotic resistance; Dairy products; Functional foods; Lactic acid bacteria; Probiotics; Safety

Indexed keywords

PROBIOTIC AGENT; TEICOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; DAIRY PRODUCT; DRUG MANUFACTURE; ENTEROCOCCUS; FOOD PROCESSING; FOOD SAFETY; LACTIC ACID BACTERIUM; LACTOBACILLUS; LACTOCOCCUS; NONHUMAN; OPPORTUNISTIC INFECTION; PLASMID; REVIEW; RISK BENEFIT ANALYSIS; STREPTOCOCCUS;

ENTEROCOCCUS; LACTOBACILLUS; LACTOCOCCUS; STREPTOCOCCUS;

EID: 0031791542     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1605(98)00128-7     Document Type: Article

References (96)

1. Adams M.R., Marteau P. On the safety of lactic acid bacteria from food. Intern. J. Food Microbiol. 27:1995;263-264.
2. Aguirre M., Collins M.D. Lactic acid bacteria and human clinical infection. J. Appl. Bacteriol. 75:1993;95-107.
3. Ahn C., Collins-Thompson D., Duncan C., Stiles M.E. Mobilization and location of the genetic determinant of chloramphenicol resistance from Lactobacillus plantarum caTC2R. Plasmid. 27:1992;169-176.
4. Alander M., Korpela R., Saxelin M., Vilpponen-Salmela T., Mattila-Sandholm T., von Wright A. Recovery of Lactobacillus rhamnosus GG from human colonic biopsies. Lett. Appl. Microbiol. 24:1997;361-364.
5. Ametrano-Vidal C., Collins-Thopson D.L. Resistance and sensitivity of meat lactic acid bacteria to antibiotics. J. Food Protect. 50:1987;737-740.
6. Arthur M., Molinas C., Depardieu F., Courvalin P. Characterization of TN1546, a Tn3 related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J. Bacteriol. 175:1993;117-127.
7. Arthur M., Reynolds P., Courvalin P. Glycopeptide resistance in enterococci. Trends Microbiol. 4:1996;401-407.
8. Axelsson L.T., Ahrne S.I.S., Andersson M.C., Stahl S.R. Identification and cloning of a plasmid encoded erythromycin resistance from Lactobacillus reuteri. Plasmid. 20:1988;171-174.
9. Billot-Klein D., Gutman L., Sablé S., Guittet E., van Heijenoort J. Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VanB-type enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides and Enterococcus gallinarum. J. Bacteriol. 176:1994;2398-2405.
10. Blancuzzi, V., Roberts, E.D., Wilson, D., Fryer, L.R., O'Byme, E.M., DiPasquale, G., 1993. Pathogenesis of Lactobacillus casei induced polyarthritis in Lewis rats: 1. Time related changes in histopathologicalhisotpahological scores and hematology, Agents Actions. 39, special conference, C183-185.
11. Bugg T.D.H., Wright G.D., Dutka-Malen S., Arthur M., Courvalin P., Walsh C.T. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of an depsipieptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry. 30:1991;10408-10415.
12. Clewell D., Yagi Y., Dunny G., Schults S. Characterization of three plasmid DNA molecules from Streptococcus faecalis. Identification of a plasmid determining erythromycin resistance. J. Bacteriol. 117:1974;283-289.
13. Cogan T.M. Susceptibility of cheese and yoghurt starters to dihydrostreptomycin, chlortetracycline and oxytetracycline. Aust. J. Dairy Technol. 17:1972;182-183.
14. Curragh H.J., Collins M.A. High levels of spontaneous drug resistance in Lactobacillus. J. Appl. Bacteriol. 73:1992;31-36.
15. Dhodapkar K.M., Henry N.K. Leuconostoc bacteremia in an infant with short-gut syndrome: case report and literature review. Mayo Clin Proc. 71:1996;1171-1174.
16. Dong M.Y., Chang T.W., Gorbach S.L. Effects of feeding Lactobacillus GG on lethal irradiation in mice. Diag. Microbiol. Infect. Dis. 7:1987;1-7.
17. Donohue D.C., Deighton M., Ahokas J.T., Salminen S., 1993. Toxicity of lactic acid bacteria. In: Saminen S., von Wright A., (Eds.), Lactic Acid Bacteria. Marcel Dekker, New York, pp. 307-313.
18. Donohue D.C., Salminen S. Safety assessment of probiotic bacteria. Asia Pac. J. Clin. Nutr. 5:1996;25-28.
19. Donohue D.C., Salminen S. Safety of Lactobacillus GG (ATCC 53103). Nutr. Today. 31:1996;12s-15s.
20. Donohue, D., Salminen, S., Marteau, P., 1998. Safety of probiotic bacteria. In: Salminen, S., von Wright, A. (Eds.), Lactic Acid Bacteria. Marcel Dekker, New York, pp. 369-384.
21. Dutta G.N., Devriese L.A. Sensitivity and resistance to growth promoting agents in animal lactobacilli. J. Appl. Bacteriol. 51:1981;283-288.
22. Dutta G.N., Devriese L.A. Degradation of macrolide-lincosamide-streptogramin antibiotics by Lactobacillus strains from animals. Ann. Microbiol. (Inst. Pasteur). 132A:1981;51-57.
23. Elisha B.G., Courvalin P. Analysis of genes encoding D-alanine: D-alanine ligase related enzymes in Leuconostoc mesenteroides and Lactobacillus spp. Gene. 152:1995;79-83.
24. Elmer G.W., Surawicz C.M., McFarland L.V. Biotherapeutic agents, A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. J. Am. Med. Assoc. 275:1996;870-876.
25. Evers S., Casadewall B., Charles M., Dutka-Malen S., Galimand M., Courvalin P. Evolution of structure and substrate specificity in D-alanine:D-alanine ligases and related enzymes. J. Mol. Evol. 42:1996;706-712.
26. B two-component regulatory system in Enterococcus faecalis V583. J. Bacteriol. 178:1996;1302-1309.
27. Facklam R.R. Recognition of group D streptococcal species of human origin by biochemical and physiological tests. Appl. Microbiol. 23:1972;1131-1139.
28. Feagan G.T. Sensitivity of cheese starters to dihydrostreptomycin, chlortetracycline and oxytetracycline. Aust. J. Dairy Technol. 17:1962;182-183.
29. Gallemore G.H., Mohon R.T., Ferguson D.A. Lactobacillus fermentum endocarditis involving a native mitral valve. J. Terun. Med. Assoc. 88:1995;306-308.
30. Gasser F. Safety of lactic acid bacteria and their occurrence in human clinical infections. Bull. Inst. Pasteur. 92:1994;45-67.
31. Horwitch C.A., Furseth H.A., Larson A.M., Jones T.L., Olliffe J.F., Spach D.H. Lactobacillemia in three patients with AIDS. Clin. Infect. Dis. 21:1995;1460-1462.
32. Handwerger S., Pucci M.J., Volk K.J., Liu J., Lee M.S. Vancomycin-resistant Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic peptidoglycan precursors that terminate in lactate. J. Bacteriol. 176:1994;260-264.
33. Huggett A., Conzelman C. EU regulation on novel foods: consequences for the food industry. Trends Food Sci. Technol. 8:1997;133-139.
34. Hugyens F. Vancomycin resistance is not inducible in Leuconostoc, Pediococcus and Enterococcus faecalis A256. S. African J. Sci. 91:1995;94-98.
35. ILSI Europe, 1993. A scientific basis for regulations on pathogenic microorganisms in foods. Summary of a workshop held in May 1993 and organised by the Scientific Committee on Microbiology, ILSI Press.
36. Ishiwa H., Iwata M. Drug resistance plasmids in Lactobacillus fermentum. J. Gen Appl. Microbiol. 26:1980;71-74.
37. Johansson M.L., Molin G., Jeppson B., Nobaek S., Ahrné S., Bengmark S. Administration of different Lactobacillus strains in fermented oatmeal soup. In vivo colonization of human intestinal mucosa and effect on the indigenous flora. Appl. Environ. Microbiol. 59:1993;15-20.
38. Kalima P., Masterton R.G., Roddie P.H., Thomas A.E. Lactobacillus rhamnosus infection in a child following bone marrow transplant. J. Infect. 32:1996;165-167.
39. Korpela R., Moilanen E., Saxelin M., Vapaasalo H. Lactobacillus rhamnosus GG (ATCC 53013) and platelet aggregation in vitro. Int. J. Food Microbiol. 37:1997;83-86.
40. Leclercq R., Curvalin P. Resistance to glycopeptides in enterococci. Clin. Infect. Dis. 24:1997;545-556.
41. Leclercq R., Derlot E., Weber M., Duval J., Courvalin P. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicr. Agent Chemother. 33:1989;10-15.
42. Lidbeck A., Gustafsson J-Å., Nord C.E. Impact of Lactobacillus acidophilus supplements on the human oropharyngeal and intestinal microflora. Scand. J. Infect Dis. 19:1987;531-537.
43. Lidbeck A., Edlund C., Gustafsson J-Å., Kager L., Nord C.E. Impact of Lactobacillus acidophilus on the normal intestinal microflora after administration of two antimicrobial agents. Infection. 16:1988;329-336.
44. Lim K.S., Huh C.S., Baek Y.J. Antimicrobial susceptibility of bifidobacteria. J. Dairy Sci. 76:1993;2168-2174.
45. Marteau P., Pochart P., Bouhnik Y., Rambaud J.C. Fate and effects of some transiting microorganisms in the human gastrointestinal tract. World Rev. Nutr. Diet. 74:1993;1-21.
46. Marteau P., Gerhardt M.F., Myara A., Bouvier E., Trivin F., Rambaud J.C. Bifidobacteria and lactobacilli ingested in fermented dairy products can metabolize bile salts in the human small intestine. Microbiol. Ecol. Health Dis. 8:1995;151-157.
47. Marteau P., Minekus M., Havenaar R., Huis in't Veld J. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and effects of bile. J. Dairy Sci. 80:1997;1031-1037.
48. Marteau P., Vaerman J.P., Dehenin J.P., Bord S., Brassart D., Pochart P., Desjeux J.F., Rambaud J.C. Effect of intrajejunal perfusion and chronic ingestion of Lactobacillus acidophilus strain La1 on serum concentrations and jejunal secretions of immunoglobulins and serum proteins in healthy humans. Gastroenterol. Clin. Biol. 21:1997;293-308.
49. Marth E.H., Ellickson B.E. Problems created by the presence of antibiotics in milk products - a review. J. Milk Food Technol. 22:1956;266-272.
50. McConnel M.A., Mercer A.A., Tannock G.W. Transfer of plasmid pAMß1 between members of the normal microflora inhabiting the murine digestive tract and modification of the plasmid in a Lactobacillus reuteri host. Microb. Ecol. Health Dis. 4:1991;343-355.
51. McFarland L., Bernasconi P. Saccharomyces boulardii: a review of an innovative biotherapeutic agent. Microbial Ecol. Health Dis. 6:1993;157-171.
52. Miettinen M., Vuopio-Varkila J., Varkila K. Production of human necrosis factor α, interleukin 6, and interleukin 10 is induced by lactic acid bacteria. Infect Immunol. 64:1996;5403-5405.
53. Miller L.G., Finegold S.M. Antibacterial sensitivity of Bifidobacterium (Lactobacillus bifidus). J. Bacteriol. 93:1967;125-130.
54. Morelli L., Sarra P.G., Bottazzi V. In vivo transfer of pAMβ1 from Lactobacillus reuteri to Enterococcus faecalis. J. Appl. Bacteriol. 65:1988;371-375.
55. Morelli L., Vescovo M., Bottazzi V. Identification of chloramphenicol resistance plasmids in Lactobacillus reuteri and Lactobacillus acidophilus. Int. J. Microbiol. 1:1983;1-5.
56. Noble W., Virani Z., Cree R.G.A. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Lett Microbiol. 93:1992;195-198.
57. Oakley H.J., Harty D.W.S., Knox K.W. Enzyme production by lactobacilli and the potential link with infective endocarditis. J. Appl. Bacteriol. 78:1995;142-148.
58. Okitsu-Negishi S., Nakano I., Suzuki K., Hashira S., Abe T., Yoshino K. The induction of cardiangitis by Lactobacillus casei cell wall in mice I. The cytokine production from murine macrophages by Lactobacillus casei cell wall extracts. Clin. Immunol. Immunopathol. 78:1996;30-40.
59. Olukoya D.K., Ebigwei S.I., Adebawo O.O., Osiyemi F.O. Plasmid profiles and antibiotic susceptibility patterns of Lactobacillus isolated from fermented foods in Nigeria. Food Microbiol. 10:1993;279-285.
60. Orrhage K., Brismar B., Nord C.E. Effect of supplements with Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin. Microb. Ecol. Health Dis. 7:1994;17-25.
61. Patel R., Cockerill F.R., Porayko M.K., Osmon D.R., Ilstrup D.M., Kenting M.R. Lactobacillemia in liver transplant patients. Clin. Infect. Dis. 18:1994;207-212.
62. Pelletier, C., Bouley, C., Bourliov, P. and Carbon, C., 1996. Evaluation of safety properties of Lactobacillus strains by using an experimental model of endocarditis in rabbit. Abstract, SOMED Meeting, Paris, 1996.
63. Perdigon G., De Jorrat M.E.B., De Petrino S.F., De Budeguer M.V. Effect of oral administration of Lactobacillus casei on various biological functions of the host. Food Agric Immunol. 3:1991;93-102.
64. Pettersson, L., Graf, W., Sewelin, U., 1983. Survival of L. acidophilus NCDO 1748 in the human gastrointestinal tract. 2. Ability to pass the stomach and intestine in vivo. In: Hallgren B. (Ed.), Nutrition and the Intestinal Flora XV, Symp. Swed. Nutr. Found, Uppsala, Almqvist & Wiksell, pp. 127-130.
65. Pletinx M., Legein J., Vandenplas Y. Fungemia with SaccharomycesSaccharomyce boulardii in a 1-year old girl with protracted diarrhoea. J. Ped. Gastroenterol. Nutr. 21:1995;113-115.
66. Raccah M., Kovac S.L., Mayer C.M. Susceptibility of meat lactic acid bacteria to antibiotics. Food Microbiol. 2:1985;271-275.
67. Reinbold G.W., Reddy M.S. Sensitivity or resistance of dairy starter and associated microorganisms to selected antibiotics. J. Milk Technol. 37:1974;517-521.
68. Reynolds P.E. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur. J. Clin. Microbial. Infect. Dis. 8:1989;943-950.
69. Richards R.J., Kennedy H.E. Antibiotic resistance of starter cultures belonging to streptococcus. J. Dairy Sci. 43:1960;852-853.
70. Rinckel L.A., Savage D.C. Characterization of plasmids and plasmid-borne macrolide resistance from Lactobacillus sp. strain 100-33. Plasmid. 23:1990;119-125.
71. Ruseler van Embden J.G.H., van der Helm R., van Licshour L.C.M. Degradation of intestinal glycoproteins by Bacteroides vulgatus. FEMS Microbiol. Lett. 58:1989;37-42.
72. Ruseler van Embden J.G., Schouten W.R., van Lieshout L.M. Pouchitis: result of microbial imbalance. Gut. 35(5):1994;658-664.
73. Ruseler van-van Embden J.G.H., van Lieshout L.M.C., Gosselink M.J., Marteau P. Inability of Lactobacillus casei strain GG, L. acidophilus, and Bifidobacterium bifidum to degrade intestinal mucus glycoproteins: clearing the way for mucosa-protective therapy. Scand. J. Gastroenterol. 30:1995;675-680.
74. Salminen S., Bouley C., Boutron-Ruault M.-C., Cummings J.H., Franck A., Gibson G.R., Isolauri E., Moreau M.C., Roberfroid M., Rowland I. Functional Food Science and Gastrointestinal Physiology and Function. Br. J. Nutr. 80(Suppl. 1):1998;S147-S171.
75. Sarra P.G., Vescovo M., Morelli L., Cabras M. Antibiotic resistance in L. acidophilus and L. reuteri from animal gut. Ann. Microbiol. Enzymol. 32:1982;71-76.
76. Sartor R.B., Bond T.M., Schwabb J.H. Systemic uptake and intestinal inflammatory effects of luminal bacterial cell wall polymers in rats with acute colonic injury. Infect. Immunol. 56:1988;2101-2108.
77. Saxelin M. Lactobacillus GG - a human probiotic strain with thorough clinical documentation. Food Rev. Int. 13:1997;293-313.
78. Saxelin M. Colonization of the human gastrointestinal tract by probiotic bacteria. Nutr. Today. 31:1996;5S-8S.
79. Saxelin M., Chuang N.H., Chassy B., Rautelin H., Mäkelä P.H., Salminen S., Gorbach S.L. Lactobacilli and bacteremia in Southern Finland, 1989-1992. Clin. Infect. Dis. 22:1996;564-566.
80. Saxelin M., Rautelin H., Salminen S., Mäkelä P.H. Safety of commercial products with viable Lactobacillus strains. Inf. Dis. Clin. Pract. 5:1996;331-335.
81. Schwabb J.H. Phlogistic properties of peptido-glycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonise humans. Infect. Immun. 61:1993;4535-4539.
82. Shlaes D.M., Bouvet A., Devine C., Shlaes J.H., Al-Obeid S., Williamson R. Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256. Antimicrob. Agents Chemother. 33:1989;198-203.
83. Sozzi T., Smiley M.B. Antibiotic resistance of yoghurt starter cultures Streptococcus thermophilus and Lactobacillus bulgaricus. Appl. Environ. Microbiol. 40:1980;862-865.
84. Tang P., Foubister V., Pucciarelli M.G., Finlay B.B. Methods to study bacterial invasion. J. Microbiol. Methods. 18:1993;227-240.
85. Tannock G.W., Kuchansky J.B., Miller L., Connel H., Thode-Andersen S., Mercer A.A., Klaenhammer T.R. Molecular characterization of a plasmid-borne (pGT633) erythromycin resistance determinant (ermGT) from Lactobacillus reuteri 100-63. Plasmid. 31:1994;60-71.
86. Torriani S., Sottili U., Giorg A., Vescovo M., Dellaglio F. Plasmid DNA and Antibiotic susceptibility in Lactobacillus strains from human vagina. Microbiol.-Aliments-Nutr. 6:1988;63-68.
87. Tynkkynen S., Singh K.V., Varmanen P. Vancomycin resistance factor in Lactobacillus rhamnosus GG is not related to enterococcal vancomycin resistance 8van)genes. Int. J. Food Microbiol. 41:1998;195-204.
88. Uttley A.H., Collins C.H., Naidoo J., George R.C. Vancomycin-resistant enterococci. Lancet. i:1988;57-78.
89. Vakil J.R., Shahani K.M. Carbohydrate metabolism of lactic acid cultures. II. Different pathway of lactose metabolism of S. lactis and their sensitivity to antibiotics. J. Dairy Sci. 52:1969;162-168.
90. Vakil J.R., Shahani K.M. Carbohydrate metabolism of lactic acid cultures III. Glycolytic enzymes of Streptococcus lactis and their sensitivity to antibiotics. Can. J. Microbiol. 15:1969;753-759.
91. Vescovo M., Morelli L., Bottazzi V. Drug resistance plasmids in Lactobacillus reuteri and Lactobacillus acidophilus. Int. J. Microbiol. 1:1982;1-5.
92. Whitehead H.R., Lane D.J. The influence of penicillin on the manufacture and ripening of cheddar cheese. J. Dairy Res. 23:1956;355-360.
93. Wolf B.W., Garleb K.A., Ataya D.G., Casas I.A. Safety and tolerance of Lactobacillus reuteri in healthy adult male subjects. Microbiol. Ecol. Health Dis. 8:1995;41-50.
94. Woodford N., Johnson A.P., Morrison D., Speller D.C.E. Current perspectives on glycopeptide resistance. Clin. Microbiol. Rev. 8:1995;585-615.
95. Zunic P., Lacotte J., Pegoix M., Buteux G., Leroy G., Mosquett B., Molin M., Fongérnie Á. Saccharomyces boulardii. Therapie. 46:1991;497-501.
96. Yokokura T., Mutai M. Penicillin resistance and its elimination by treatment with acriflavine in Lactobacillus fermentum. Jap. J. Microbiol. 20:1976;241-242.